Revelol-CH 50/6.25 Tablet ER
By Revelol-CH
Rx
10 Tablet ER in a Strip

Composition
Metoprolol Succinate(50mg) + Chlorthalidone(6.25mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
January, 2026

liver
When taking Revelol-CH 50/6.25 Tablet ER, it is important to be cautious if you have liver disease. Patients with liver issues may require a dosage adjustment, so make sure to consult your doctor before starting this medication. It is advised not to use Revelol-CH 50/6.25 Tablet ER in cases of severe liver disease. Monitoring and professional medical advice are crucial for individuals with liver problems while using this medication.

kidney
Revelol-CH 50/6.25 Tablet ER needs caution in severe kidney disease. Adjusting the dose may be necessary, and it's best to consult your doctor. Avoid using this medication in such patients.

alcohol
It is considered risky to drink alcohol while taking Revelol-CH 50/6.25 Tablet ER.

driving
Revelol-CH 50/6.25 Tablet ER may lower alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if these effects happen.

pregnancy
Revelol-CH 50/6.25 Tablet ER may not be safe to use during pregnancy, as animal studies have indicated potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Revelol-CH 50/6.25 Tablet ER is considered safe to use during breastfeeding based on limited data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹123.66
₹137.4
10% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024